Sabra Health Care REIT, Inc. (SBRA)
$
18.91
+0.28 (1.48%)
Key metrics
Financial statements
Free cash flow per share
1.4238
Market cap
4.4 Billion
Price to sales ratio
6.0386
Debt to equity
0.6492
Current ratio
0.1421
Income quality
1.8584
Average inventory
0
ROE
0.0669
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
As of March 31, 2022, Sabra's investment portfolio featured 416 real estate properties held for investment, which incorporated a variety of facilities, including 279 Skilled Nursing/Transitional Care facilities, 59 Senior Housing communities categorized as Senior Housing - Leased, and 50 other Senior Housing communities managed by third-party property managers under property management agreements classified as Senior Housing - Managed. Additionally, the portfolio consisted of 13 Behavioral Health facilities and 15 Specialty Hospitals and other facilities. The cost of revenue for the company is $227,088,000.00 showcasing its production and operational expenses, while the gross profit stands at $476,147,000.00 highlighting the company's profitability from core operations. Furthermore, the company incurred an income tax expense of $1,005,000.00 indicating its tax obligations. The total costs and expenses for the company are $446,207,000.00 reflecting its overall spending. In the realm of financial investments, the company earned an interest income of $0.00 showcasing its strategic ventures. Sabra's real estate properties held for investment included a total of 41,445 beds/units, distributed across the United States and Canada. Moving on to the stock performance, it is currently considered affordable at $18.76 making it suitable for budget-conscious investors. The stock has a high average trading volume of 2,571,825.00 indicating strong liquidity in the market. With a mid-range market capitalization of $4,534,466,720.00 the company stands out as a steady performer in its sector. It is a key player in the REIT - Healthcare Facilities industry, contributing significantly to the overall market landscape and driving innovation and growth within the Real Estate sector. The combination of affordability, liquidity, and strategic positioning of the company underscores its potential as an attractive investment option for various investors.
Investing in Sabra Health Care REIT, Inc. (SBRA) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict Sabra Health Care REIT, Inc. stock to fluctuate between $15.60 (low) and $20.03 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-08-20, Sabra Health Care REIT, Inc.'s market cap is $4,534,466,720, based on 239,792,000 outstanding shares.
Compared to PROLOGIS, INC., Sabra Health Care REIT, Inc. has a Lower Market-Cap, indicating a difference in performance.
Sabra Health Care REIT, Inc. pays dividends. The current dividend yield is 6.50%, with a payout of $0.30 per share.
To buy Sabra Health Care REIT, Inc. (SBRA) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for SBRA. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Sabra Health Care REIT, Inc.'s last stock split was 1:3 on 2010-11-16.
Revenue: $703,235,000 | EPS: $0.54 | Growth: 807.56%.
Visit https://www.sabrahealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $20.03 (2024-11-12) | All-time low: $10.08 (2023-03-24).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
prnewswire.com
BEND, Ore. , Aug. 20, 2025 /PRNewswire/ -- Sunshine Retirement Living, a leading provider of mid-market senior living communities in the United States, is expanding its national footprint through a new management agreement with Sabra Health Care REIT, Inc. (Nasdaq: SBRA). This agreement adds five independent living communities across four Western states, growing Sunshine Retirement Living's portfolio from 35 to 40 communities in 17 states.
seekingalpha.com
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q2 2025 Earnings Conference Call August 5, 2025 1:00 PM ET Company Participants Lukas Michael Hartwich - Executive Vice President of Finance Michael Lourenco Costa - Executive VP, CFO & Secretary Richard K. Matros - Chairman, President & CEO Talya Nevo-Hacohen - Executive VP, Chief Investment Officer & Treasurer Conference Call Participants Alec Gregory Feygin - Robert W.
zacks.com
Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zacks.com
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.38 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to FFO of $0.36 per share a year ago.
seekingalpha.com
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q1 2025 Results Conference Call May 6, 2025 1:00 PM ET Company Participants Lukas Hartwich - EVP, Finance Rick Matros - Chief Executive Officer, President & Chair Talya Nevo-Hacohen - CIO, Treasurer & EVP Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank Farrell Granath - Bank of America Austin Wurschmidt - KeyBanc Capital Markets Juan Sanabria - BMO Capital Markets Seth Bergey - Citi George Dugan - Mizuho Securities Richard Anderson - Wedbush Alec Feygin - Baird Equity Research Operator Good day, everyone. My name is Kate, and I will be your conference operator today.
zacks.com
The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
seekingalpha.com
Sabra Health Care REIT's strong fundamentals, 6.62% dividend yield, and low forward multiple make it an attractive investment amid tariff uncertainties and potential recession. The REIT's solid growth in FFO, AFFO, and revenue, driven by increased occupancy rates and NOI growth, highlights its resilience in a challenging economic environment. Sabra's well-positioned balance sheet, with robust liquidity and deleveraging efforts, ensures stability and growth potential, even during economic downturns.
businesswire.com
TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Talya Nevo-Hacohen, Sabra's Chief Investment Officer, Treasurer and Executive Vice President, has decided to retire effective December 31, 2025 and Darrin Smith, Sabra's Executive Vice President, Investments, is expected to be elevated to the role of Sabra's Chief Investment Officer effective January 1, 2026. Ms. Nevo-Hacohen is expected to remain in a consulting role with Sabra pursuant.
seekingalpha.com
Sabra Health Care REIT, Inc. offers a 6.7% dividend yield, benefiting from strong fundamentals, favorable demographics, and a well-managed balance sheet. Management is guiding for AFFO growth, supported by rising occupancy, stable reimbursement rates, and a robust acquisition pipeline in skilled nursing. SBRA stock trades at a reasonable valuation with a forward P/FFO of 12.2, positioning it for potential market-beating total returns.
See all news